BSE
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Company News Details
Ishita Drugs & Industries Ltd Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
524400
ISIN Demat
INE806D01016
Book Value (Rs)
38.6883488
NSE Symbol
N.A
Divident Yield %
0
Market Cap
(Rs In Cr.)
21
P/E (TTM)
30.15
EPS (TTM)
2.36
Face Value
(Rs)
10
Back
Ishita Drugs & Industries standalone net profit declines 23.33% in the June 2026 quarter
08-Aug-26   Hrs IST

Net profit of Ishita Drugs & Industries declined 23.33% to Rs 0.23 crore in the quarter ended June 2026 as against Rs 0.30 crore during the previous quarter ended June 2025. Sales declined 41.67% to Rs 3.15 crore in the quarter ended June 2026 as against Rs 5.40 crore during the previous quarter ended June 2025.

ParticularsQuarter Ended
Jun. 2026Jun. 2025% Var.
Sales3.155.40 -42
OPM %9.846.48 -
PBDT0.350.42 -17
PBT0.300.39 -23
NP0.230.30 -23

Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, Developed , Maintained and Content Powered by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)